Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0TG9Q
|
||||
Former ID |
DIB010467
|
||||
Drug Name |
MK-0812
|
||||
Synonyms |
C-6448; MK-812; CCR2 antagonist (rheumatoid arthritis/multiple sclerosis), Merck
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Multiple scierosis [ICD9: 340; ICD10:G35] | Phase 2 | [521746] | ||
Company |
Merck & Co Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H34F3N3O3
|
||||
Canonical SMILES |
C1OCCC([C@@H]1OC)N[C@@H]1CC[C@](C1)(C(C)C)C(=O)N1CCc2c(<br />C1)cc(cn2)C(F)(F)F
|
||||
CAS Number |
CAS 1011472-76-6
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | C-C chemokine receptor type 2 | Target Info | Antagonist | [530515] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.